Pui–Chee Wu
Impact in
- Hepatology top 0.2%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis Viruses Studies and Epidemiology
- Liver Disease and Transplantation
- Epidemiology top 0.5%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 15
- Hepatitis B Virus Studies 11
- Liver Disease Diagnosis and Treatment 7
- Hepatology 12
- Hepatitis C virus research 11
- Hepatitis Viruses Studies and Epidemiology 2
- Liver Disease and Transplantation 2
- Co-authors
- Ching‐Lung Lai (19 shared papers)Dar‐In Tai (1 shared paper)Ting‐Tsung Chang (1 shared paper)Richard Guan (1 shared paper)Rong‐Nan Chien (1 shared paper)DF Gray (1 shared paper)Judy Barber (1 shared paper)Sally L. Stephenson (1 shared paper)
- Journals
- Gastroenterology (3 papers)Cancer (3 papers)Hepatology (2 papers)Journal of Gastroenterology and Hepatology (2 papers)American Journal of Clinical Pathology (2 papers)
- Partner nations
- Hong KongChinaUnited States
In The Last Decade
Pui–Chee Wu
24 papers receiving 3.1k citations
Pui–Chee Wu's Hit Papers
Peers
Comparison fields: 5 of 91
- Hepatology 1.9k
- Epidemiology 2.4k
- Infectious Diseases 394
- Pharmacology 153
- Oncology 190
Countries citing papers authored by Pui–Chee Wu
This map shows the geographic impact of Pui–Chee Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pui–Chee Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pui–Chee Wu more than expected).
Fields of papers citing papers by Pui–Chee Wu
This network shows the impact of papers produced by Pui–Chee Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pui–Chee Wu. The network helps show where Pui–Chee Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Pui–Chee Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A One-Year Trial of Lamivudine for Chronic Hepatitis B Hit paper breakdown → | 1998 | 1424 |
| 2 | 1988 | 292 | |
| 3 | 1987 | 241 | |
| 4 | 1992 | 202 | |
| 5 | 2000 | 178 | |
| 6 | 1993 | 176 | |
| 7 | 1988 | 148 | |
| 8 | 1987 | 125 | |
| 9 | 2001 | 122 | |
| 10 | 1998 | 65 | |
| 11 | 1985 | 46 | |
| 12 | 1987 | 27 | |
| 13 | 1994 | 23 | |
| 14 | 1996 | 23 | |
| 15 | 1989 | 16 | |
| 16 | 1993 | 15 | |
| 17 | 1985 | 14 | |
| 18 | 1987 | 13 | |
| 19 | 2000 | 11 | |
| 20 | 2008 | 10 |
About Pui–Chee Wu
Pui–Chee Wu is a scholar working on Epidemiology, Hepatology, Molecular Biology, Infectious Diseases and Surgery, having authored 24 papers that have together received 3.2k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (11 papers), Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (7 papers), Hepatitis Viruses Studies and Epidemiology (2 papers), Liver Disease and Transplantation (2 papers), Folate and B Vitamins Research (1 paper), Antifungal resistance and susceptibility (1 paper) and Chemotherapy-induced cardiotoxicity and mitigation (1 paper). The work is most often cited by research in Hepatology (1.9k citations), Epidemiology (2.4k citations), Infectious Diseases (394 citations), Pharmacology (153 citations) and Oncology (190 citations). Pui–Chee Wu has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Ching‐Lung Lai, Dar‐In Tai, Ting‐Tsung Chang, Richard Guan, Rong‐Nan Chien, DF Gray, Judy Barber, Sally L. Stephenson, Nancy W.Y. Leung and Hsiang‐Ju Lin. Their work appears in journals such as Gastroenterology, Cancer, Hepatology, Journal of Gastroenterology and Hepatology and American Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.